Clinical Trial

ACTG2/FLNA Testing Yield in Adult Idiopathic Chronic Intestinal Pseudo-Obstruction (CIPO) With Reduced/Absent Distal Esophageal Contractility

Study acronym: CIPO_GEN
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
To assess the diagnostic yield of Sanger sequencing for ACTG2 and FLNA genes evaluation on blood or saliva sample in patients with idiopathic CIPO in which high-resolution esophageal manometry (HRM) shows reduced (DCI \<450 mmHg\*s\*cm) or absent distal esophageal contractility.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-25.
Trial Details
NCT Number NCT07448753
Lead Sponsor Marina Coletta
Collaborators: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Nottingham University Hospitals NHS Trust
Conditions Pseudo Obstruction
Enrollment 20 participants
Start Date 2025-09-17
Primary Completion 2026-09-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-05